These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

554 related items for PubMed ID: 7038299

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. ELISA & lepromin skin tests in household contacts of leprosy patients.
    Dhandayuthapani S, Anandan D, Bhatia VN.
    Indian J Med Res; 1990 Nov; 91():431-6. PubMed ID: 2091988
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Leucocyte migration inhibition response of Mycobacterium habana with sensitized animals and cells from leprosy patients.
    Singh NB, Gupta HP, Mathur IS, Kumar A, Chakraborty SK.
    Indian J Lepr; 1985 Nov; 57(2):273-7. PubMed ID: 3935726
    [Abstract] [Full Text] [Related]

  • 26. Immunity to leprosy and the Mitsuda reaction.
    Shepard CC.
    Int J Lepr Other Mycobact Dis; 1984 Mar; 52(1):74-7. PubMed ID: 6368430
    [No Abstract] [Full Text] [Related]

  • 27. [The lymphocyte transformation test using phytohemagglutinin, lepromin and M. leprae in lepromin-negative and positive leprosy: prognostic value compared with that of lepromin].
    Pagnano PM, Bechelli LM, de Lima Filho EC.
    Acta Leprol; 1982 Mar; (86-87):83-95. PubMed ID: 6816002
    [No Abstract] [Full Text] [Related]

  • 28. Early and late reactions in tuberculoid and lepromatous leprosy patients with lepromins from Mycobacterium leprae and five selected cultivable mycobacteria.
    Mustafa AS, Talwar GP.
    Lepr India; 1978 Oct; 50(4):566-71. PubMed ID: 374875
    [No Abstract] [Full Text] [Related]

  • 29. Susceptibility to leprosy may be conditioned by an interaction between the NRAMP1 promoter polymorphisms and the lepromin response.
    Ferreira FR, Goulart LR, Silva HD, Goulart IM.
    Int J Lepr Other Mycobact Dis; 2004 Dec; 72(4):457-67. PubMed ID: 15755200
    [Abstract] [Full Text] [Related]

  • 30. Interferon-gamma responses to candidate leprosy skin-test reagents detect exposure to leprosy in an endemic population.
    Manandhar R, LeMaster JW, Butlin CR, Brennan PJ, Roche PW.
    Int J Lepr Other Mycobact Dis; 2000 Mar; 68(1):40-8. PubMed ID: 10834068
    [Abstract] [Full Text] [Related]

  • 31. Vaccination of human volunteers with heat-killed M. leprae: local responses in relation to the interpretation of the lepromin reaction.
    Gill HK, Mustafa AS, Godal T.
    Int J Lepr Other Mycobact Dis; 1988 Mar; 56(1):36-44. PubMed ID: 3286799
    [Abstract] [Full Text] [Related]

  • 32. T lymphocyte reactivity of leprosy patients and healthy contacts from a leprosy-endemic population to delipidified cell components of Mycobacterium leprae.
    Ilangumaran S, Robinson P, Shankernarayan NP, Ramu G, Mahadevan PR, Muthukkaruppan VR.
    Lepr Rev; 1994 Mar; 65(1):34-44. PubMed ID: 8201834
    [Abstract] [Full Text] [Related]

  • 33. Cultivable precursors of Mycobacterium leprae.
    Chatterjee BR.
    Lepr India; 1980 Oct; 52(4):513-26. PubMed ID: 7007724
    [Abstract] [Full Text] [Related]

  • 34. Filter paper blood spot test for detection of anti-ND-BSA antibodies in school children.
    Sahasrabudhe R, Dandekar S, Shah DH, Naik S, Ganapathi R.
    Indian J Med Res; 1992 May; 95():105-11. PubMed ID: 1506059
    [Abstract] [Full Text] [Related]

  • 35. Fluorescent leprosy antibody absorption (FLA-ABS) test for detecting subclinical infection with Mycobacterium leprae.
    Abe M, Minagawa F, Yoshino Y, Ozawa T, Saikawa K, Saito T.
    Int J Lepr Other Mycobact Dis; 1980 Jun; 48(2):109-19. PubMed ID: 6156918
    [No Abstract] [Full Text] [Related]

  • 36. [Correlation of skin tests and the production of gamma-interferon in leprosy patients].
    Suso L, Nogueira N, Vieira LM, Figueiredo AA, Porto JA, Sarno EN.
    Med Cutan Ibero Lat Am; 1988 Jun; 16(3):193-6. PubMed ID: 3143869
    [Abstract] [Full Text] [Related]

  • 37. Induction of lepromin positivity following immuno-chemotherapy with Mycobacterium w vaccine and multidrug therapy and its impact on bacteriological clearance in multibacillary leprosy: report on a hospital-based clinical trial with the candidate antileprosy vaccine.
    Sharma P, Kar HK, Misra RS, Mukherjee A, Kaur H, Mukherjee R, Rani R.
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):259-69. PubMed ID: 10575405
    [Abstract] [Full Text] [Related]

  • 38. The Kveim test in leprosy.
    Krishnamurthy S, Verghese R, Job CK.
    Int J Lepr Other Mycobact Dis; 1975 Sep; 43(4):333-8. PubMed ID: 1241690
    [Abstract] [Full Text] [Related]

  • 39. Human vaccination studies in normal and contacts of leprosy patients.
    Samuel NM, Stanford JL, Rees RJ, Fairbairn T, Adiga RB.
    Indian J Lepr; 1984 Sep; 56(1):36-47. PubMed ID: 6384380
    [No Abstract] [Full Text] [Related]

  • 40. Skin test development in leprosy: progress with first-generation skin test antigens, and an approach to the second generation.
    Brennan PJ.
    Lepr Rev; 2000 Dec; 71 Suppl():S50-4. PubMed ID: 11201887
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.